Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-10-22
1985-06-18
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549480, A61K 3134, C07D30789
Patent
active
045240760
ABSTRACT:
This application relates to 4-amino-4,5-dihydro-2-furancarboxylic acid, and esters thereof, useful as .gamma.-aminobutyric acid transaminase inhibitors.
REFERENCES:
patent: 3306899 (1967-02-01), Dowbenko
patent: 3347872 (1967-10-01), Passannante et al.
patent: 3983134 (1976-09-01), Matsui et al.
Lippert Bruce J.
Metcalf Brian W.
McDonald Raymond A.
Merrell Dow Pharmaceuticals Inc.
Nesbitt Stephen L.
Siegel Alan
Street Gary D.
LandOfFree
Novel .gamma.-aminobutyric acid transaminase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel .gamma.-aminobutyric acid transaminase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel .gamma.-aminobutyric acid transaminase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-979372